Mass Spectrometry: In-Depth Focus 2016
Posted: 4 May 2016 | European Pharmaceutical Review | No comments yet
In this Mass Spectrometry In-Depth Focus: Novel trends in glycosylation analysis of biotherapeutics by mass spectrometry; The use of mass spectrometry for the characterisation of proteins in small molecule drug discovery; Mass Spectrometry Q&A…
- Novel trends in glycosylation analysis of biotherapeutics by mass spectrometry
Pilsoo Kang and Jianmei Kochling, Sanofi and Hanjo Lim, Genentech - The use of mass spectrometry for the characterisation of proteins in small molecule drug discovery
Rick A. Davies, Melanie Snow and Jonathan Renshaw, AstraZeneca - Mass Spectrometry Q&A
With Geoffrey McConnell, Product Manager, Analytical, at PALL Laboratory
This Mass Spectrometry In-Depth Focus is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Issue
Related topics
Related organisations
AstraZeneca, Charles River, Genentech, IonBench, Pall Laboratory, Sanofi
Related people
Geoffrey McConnell, Hanjo Lim, Jianmei Kochling, Jonathan Renshaw, Melanie Snow, Pilsoo Kang, Rick A. Davies
